March 2026Peptide Sciences shut down by FDA. Full breakdown
Price Intelligence · May 2026
Here Is What Peptides Actually Cost.
(And here is what some people are being charged, which is a different number.)
Twenty-five years of analyzing $10 billion in enterprise transactions taught me one thing that applies equally to data centers, cloud contracts, and peptide vials: the information asymmetry IS the markup. When you don't know what something should cost, you pay whatever you're told. This page fixes that.
Sort:
| Compound | Research Vendor | Telehealth / Rx | Monthly Est. | Value Verdict |
|---|---|---|---|---|
| BPC-157 (5mg x10 vials) | $45–$90 | $150–$400 | $45–$400 | Research wins on price. Same molecule. |
| CJC-1295 / Ipamorelin (stack) | $80–$160 | $250–$600 | $80–$600 | Compounding pharmacy is legit. At a price. |
| Epithalon (10mg x10 vials) | $60–$120 | N/A | $60–$120 | Longevity stack workhorse. Inexpensive. |
| GHK-Cu (50mg topical/injection) | $25–$60 | N/A | $25–$60 | Skin and wound applications. Very cheap. |
| MOTS-c (10mg) | $90–$200 | N/A | $90–$200 | Metabolic / longevity. Emerging data. |
| PT-141 (10mg x5 vials) | $50–$100 | $200–$400 | $50–$400 | FDA-approved version exists. Compare. |
| Retatrutide (experimental) | $200–$450 | N/A | $200–$450 | Telehealth path doesn't exist yet. |
| Selank (5mg x10 vials) | $35–$70 | N/A | $35–$70 | Low cost, no telehealth path, straightforward. |
| Semaglutide (per month) | $120–$250 | $400–$900 | $400–$900 | Pharma litigation = supply risk. Factor it in. |
| Semax (5mg x10 vials) | $40–$80 | N/A | $40–$80 | Same story as Selank. |
| SS-31 (Elamipretide, 10mg) | $80–$180 | N/A | $80–$180 | Mitochondrial. No Rx path yet. |
| TB-500 (5mg x4 vials) | $60–$120 | $200–$500 | $60–$500 | Telehealth premium: 3–4x. Decide accordingly. |
| Thymosin Alpha-1 (1mg x10) | $70–$150 | $300–$700 | $70–$700 | Immune support. Telehealth premium steep. |
| Tirzepatide (per month) | $150–$300 | $500–$1,200 | $500–$1,200 | Novo is actively suing suppliers. Risk premium real. |
Tony's Takes
BPC-157: "The most overhyped and underpriced peptide in the space. Both true at once."
CJC-1295 / Ipamorelin: "The stack that made peptides mainstream. Pricing reflects that."
Semaglutide: "Ozempic in a research vial. The economics are wild until they aren't."
Retatrutide: "Next-gen GLP-1. No telehealth path yet. Give it 18 months."
What Will Your Protocol Actually Cost Per Month?
Select up to 4 compounds. Choose pricing source. See your monthly estimate.
Research vendor sourcing involves regulatory considerations. See What's Legal for full context.